Literature DB >> 23555344

The Clinical Course of Buerger's Disease.

Takashi Ohta1, Hiroyuki Ishibashi, Ikuo Sugimoto, Hirohide Iwata, Jun Kawanishi, Tetsuya Yamada, Masao Tadakoshi, Noriyuki Hida.   

Abstract

The clinical and social characteristics of 118 patients with Buerger's disease (thromboangiitis obliterans: TAO) were surveyed. The prognosis for many patients is relatively favorable. Arterial reconstruction plays a role in shortening the healing times of ischemic ulcers despite its poor long-term results. Of 118 patients, 13 underwent major lower limb amputation (11%), 33 underwent foot or toe amputation (28%), one underwent hand amputation (1%), and 12 underwent finger amputations (10%) after the onset of the disease. The progression of symptoms was surely influenced by smoking, but this was not the only deleterious factor as there were patients with stable TAO which was unaffected by their continued smoking. In 66 patients, the new occurrence of ulceration and gangrene was not observed over the age of 60. Ten of 13 patients (77%) who underwent major lower limb amputation lost their jobs, but only 7 of 105 patients without major amputation lost their jobs (7%). In all patients, the progression of symptoms was self-limited and recurrent ulcers occurred less frequently with ageing. To avoid factors that markedly influence the quality of life, early treatment and strict instructions prohibiting smoking should be conducted.

Entities:  

Keywords:  Buerger's disease (TAO); job loss; prognosis; quality of life; smoking

Year:  2008        PMID: 23555344      PMCID: PMC3595730          DOI: 10.3400/avd.AVDct00208

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  7 in total

1.  THROMBOANGIITIS OBLITERANS AND ARTERIOSCLEROSIS OBLITERANS. CLINICAL AND PROGNOSTIC DIFFERENCES.

Authors:  J R MCPHERSON; J L JUERGENS; R W GIFFORD
Journal:  Ann Intern Med       Date:  1963-09       Impact factor: 25.391

2.  The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease).

Authors:  J W Olin; J R Young; R A Graor; W F Ruschhaupt; J R Bartholomew
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

3.  Fate of the ischaemic limb in Buerger's disease.

Authors:  T Ohta; S Shionoya
Journal:  Br J Surg       Date:  1988-03       Impact factor: 6.939

4.  What is Buerger's disease?

Authors:  S Shionoya
Journal:  World J Surg       Date:  1983-07       Impact factor: 3.352

5.  Decrease in prevalence of Buerger's disease in Japan.

Authors:  M Matsushita; N Nishikimi; T Sakurai; Y Nimura
Journal:  Surgery       Date:  1998-09       Impact factor: 3.982

6.  Current status of thromboangiitis obliterans (Buerger's disease) in Japan.

Authors:  S Sasaki; M Sakuma; K Yasuda
Journal:  Int J Cardiol       Date:  2000-08-31       Impact factor: 4.164

7.  Role of infrainguinal bypass in Buerger's disease: an eighteen-year experience.

Authors:  T Sasajima; Y Kubo; M Inaba; K Goh; N Azuma
Journal:  Eur J Vasc Endovasc Surg       Date:  1997-02       Impact factor: 7.069

  7 in total
  2 in total

1.  Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients.

Authors:  Alexandre Le Joncour; Simon Soudet; Axelle Dupont; Olivier Espitia; Fabien Koskas; Philippe Cluzel; Pierre Yves Hatron; Joseph Emmerich; Patrice Cacoub; Matthieu Resche-Rigon; Marc Lambert; David Saadoun
Journal:  J Am Heart Assoc       Date:  2018-12-04       Impact factor: 5.501

Review 2.  Buerger's Disease May be a Chronic Rickettsial Infection with Superimposed Thrombosis: Literature Review and Efficacy of Doxycycline in Three Patients.

Authors:  Moon-Hyun Chung; Jin-Soo Lee; Jae-Seung Kang
Journal:  Infect Chemother       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.